Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose and Metformin Loose-Dose Combination in T2DM
NCT03349684Phase 3Completed
- Sponsor
- Bayer
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by Bayer. Started Mar 2018; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03349684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349684.